Method of treating ophthalmic disorders using TGF -.beta.

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5767079
SERIAL NO

08705694

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention is a method for the treatment of ophthalmic disorders. The method is suitable for treatment of a variety of disorders including macular holes, macular degeneration, and retinal detachment and tears, cataracts, and corneal and scleral injuries. The method entails application of an effective amount of Transforming Growth Factor-.beta. (TGF-.beta.) to the affected region.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CELTRIX PHARMACEUTICALS INC2500 FABER PLACE PALO ALTO CA 94303 UNITED STATES OF AMERICA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Glaser, Bert M Baltimore, MD 4 186
Hanham, Ann F Palo Alto, CA 1 105
Ksander, George A Redwood City, CA 2 187
Pharriss, deceased Bruce B late of Palo Alto, CA 1 105

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation